[R01] Determining the performance and accuracy of SILVAMP TB LAM and cost-effectiveness of diagnostic testing for TB meningitis
Ente: National Institute of Allergy and Infectious Diseases
Scadenza: 2027-05-31
Importo max: $560,418
Paese: US
Descrizione
Project Summary
Tuberculous meningitis (TBM) is the second most common cause of meningitis in Sub-Saharan Africa.
Neurologic disability and mortality are common, mortality is at least 50% in people with HIV. TBM diagnosis
remains difficult and diagnostic delay/missed diagnosis are major contributor
Settori: National Institute of Allergy and Infectious Diseases
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.